Abstract
A bimodal target-specific contrast agent based on a cyclic peptide contg. the target-specific NGR sequence, gadolinium(III) diethylenetriaminepentaacetic acid (Gd(III)DTPA), and Oregon Green 488 (OG488) suitable for both MR imaging and optical imaging of angiogenesis is developed. The synthetic strategy for this target-specific contrast agent exploits the use of highly efficient, chemoselective reactions, such as native chem. ligation, and gives a straightforward approach for double labeling of peptides in general.
Original language | English |
---|---|
Pages (from-to) | 4857-4860 |
Journal | Organic Letters |
Volume | 6 |
Issue number | 26 |
DOIs | |
Publication status | Published - 2004 |